$GYRE SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers THIS EMPLOYMENT AGREEMENT (this “Agreement”), dated as of October 16, 2026, by and between Gyre Therapeutics, Inc., a Delaware corporation (the “Company”), and Ying Luo (the “Executive”).
01 Sep 2026	8-K: Regulation FD Disclosure
31 Aug 2026	S-8
26 Aug 2026	8-K: Regulation FD Disclosure
07 Aug 2026	10-Q
07 Aug 2026	8-K: Results of Operations and Financial Condition
04 Aug 2026	Form 4: Weston Claire, Director Granted 40,000 Stock Option (Right to Buy)
04 Aug 2026	Form 4: Kirkby Maxwell, Director Granted 40,000 Stock Option (Right to Buy)
04 Aug 2026	Form 3: Weston Claire, Director No securities owned
04 Aug 2026	Form 3: Kirkby Maxwell, Director No securities owned
03 Aug 2026	EFFECT
16 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
15 Jul 2026	8-K/A: Results of Operations and Financial Condition To the Shareholders and the Board of Directors of Cullgen Inc.
13 Jul 2026	S-3/A
30 Jun 2026	Form 4: Carmichael Gordon, Director Granted 40,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Epstein David M., Director Granted 40,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Weng Dan, Director Granted 40,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Parry Renate, Director Granted 40,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Zhang Ping, Director Granted 40,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Nussbaum Rodney L, Director Granted 40,000 Stock Option (Right to Buy)

Comments